Yahoo Italia Ricerca nel Web

Risultati di ricerca

  1. 28 ott 2022 · Il nome dice poco: Heiko.Il cognome molto di più: von der Leyen.Quando lo scorso giugno è stato associato alla Fondazione creata dall’università di Padova per gestire il filone di ricerca su terapia genica e farmaci a Rna con un piano finanziato dal Pnrr con 320 milioni di euro, un europarlamentare della Lega, Francesca Donato, aveva parlato di possibile conflitto d’interessi.

  2. Heiko von der Leyen is Dir:Medical at Orgenesis Inc. See Heiko von der Leyen's compensation, career history, education, & memberships.

  3. 26 ott 2022 · Ursula von der Leyen, presidente della Commissione europea, e il marito Heiko si ritrovano protagonisti di un nuovo caso, approfondito dalla trasmissione “Fuori dal Coro”, condotta da Mario ...

  4. Keeping our promise to Europe. When the von der Leyen Commission took office in December 2019, we made a pledge to Europe: we promised to be bold and ambitious. We vowed to meet the aspirations of EU citizens and to address challenges as they emerged. Since then, this Commission has worked tirelessly to deliver on the job with which the ...

  5. 10 mar 2023 · Heiko von der Leyen was then elected to sit on the supervisory board of the project. He resigned after Italian media drew attention to his role. The Commission president's public declaration of interest hadn’t originally listed her spouse’s stint on the board, and was only updated after Italian media reports.

  6. 8 mag 2024 · Ihr Name deutet es bereits an, es stimmt aber nur zum Teil: Denn Ursula von der Leyen stammt nicht aus einem Adelsgeschlecht, hat aber in eines eingeheiratet.Ihr Mann Heiko stammt aus dem Haus von ...

  7. 15 nov 2022 · Heiko von der Leyen, a doctor and scientific director of the US biotech company Orgenesis, which specialises in cell and gene therapies and is a frontrunner in the development of RNA COVID vaccines, is involved in the foundation established by the University of Padua on 8 June 2022 to manage research into RNA gene therapy and pharmaceuticals.